Search Results - "Ho, W M"

Refine Results
  1. 1
  2. 2

    Drug interactions with cannabinoids by Antoniou, Tony, Bodkin, Jack, Ho, Joanne M-W

    “…Antoniou et al present several facts about drug interactions with cannabinoids. Among other things, cannabinoids can affect levels of other drugs. Cannabidiol…”
    Get full text
    Journal Article
  3. 3

    Global incidence of prostate cancer in developing and developed countries with changing age structures by Teoh, Jeremy Y C, Hirai, Hoyee W, Ho, Jason M W, Chan, Felix C H, Tsoi, Kelvin K F, Ng, Chi Fai

    Published in PloS one (24-10-2019)
    “…To investigate the global incidence of prostate cancer with special attention to the changing age structures. Data regarding the cancer incidence and…”
    Get full text
    Journal Article
  4. 4

    Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers by Holbrook, Anne, Wang, Mei, Swinton, Marilyn, Troyan, Sue, Ho, Joanne M. W, Siegal, Deborah M

    Published in PloS one (29-09-2021)
    “…Background Oral anticoagulants (OACs) are very commonly prescribed for prevention of serious vascular events, but are also associated with serious…”
    Get full text
    Journal Article
  5. 5

    Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators by Hart, Kathryn M, Moeder, Katelyn E, Ho, Chris M W, Zimmerman, Maxwell I, Frederick, Thomas E, Bowman, Gregory R

    Published in PloS one (01-06-2017)
    “…Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or active sites, make it possible to target proteins considered…”
    Get full text
    Journal Article
  6. 6

    Efficiency and effectiveness of geriatric drug infographics: A randomized, controlled trial by Tung, Jennifer, Bodkin, R. Jack, Laughton, Thomas, Neat, Cameron, Benjamin, Sophiya, An, Howard, Antoniou, Tony, Ho, Joanne M.‐W.

    “…Adverse drug events (ADEs) are a leading cause of mortality, disability, and healthcare costs in older adults due to multimorbidity, age-related changes to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain–domain interactions by Frieden, Carl, Wang, Hanliu, Ho, Chris M. W.

    “…Relative to the apolipoprotein E (apoE) E3 allele of the APOE gene, apoE4 strongly increases the risk for the development of late-onset Alzheimer’s disease…”
    Get full text
    Journal Article
  9. 9

    EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone by Takyar, Farzin M, Tonna, Stephen, Ho, Patricia WM, Crimeen‐Irwin, Blessing, Baker, Emma K, Martin, T John, Sims, Natalie A

    Published in Journal of bone and mineral research (01-04-2013)
    “…Previous reports indicate that ephrinB2 expression by osteoblasts is stimulated by parathyroid hormone (PTH) and its related protein (PTHrP) and that…”
    Get full text
    Journal Article
  10. 10

    Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo by Ho, P W M, Goradia, A, Russell, M R, Chalk, A M, Milley, K M, Baker, E K, Danks, J A, Slavin, J L, Walia, M, Crimeen-Irwin, B, Dickins, R A, Martin, T J, Walkley, C R

    Published in Oncogene (28-05-2015)
    “…Osteosarcoma (OS) is the most common cancer of bone. Parathyroid hormone (PTH) regulates calcium homeostasis and bone development, while the…”
    Get full text
    Journal Article
  11. 11

    Adults with autism are less proficient in identifying biological motion actions portrayed with point‐light displays by Hsiung, E.‐Y., Chien, S. H.‐L., Chu, Y.‐H., Ho, M. W.‐R.

    “…Background Whether individuals with autism spectrum disorder (ASD) have impairments with biological motion perception has been debated. The present study…”
    Get full text
    Journal Article
  12. 12

    Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy by YEO, W, ZEE, B, ZHONG, S, CHAN, P. K. S, WONG, W-L, HO, W. M, LAM, K. C, JOHNSON, P. J

    Published in British journal of cancer (05-04-2004)
    “…For cancer patients with chronic hepatitis B virus (HBV) infection, who receive cytotoxic chemotherapy, HBV reactivation is a well-described complication,…”
    Get full text
    Journal Article
  13. 13

    Modelling proteins’ hidden conformations to predict antibiotic resistance by Hart, Kathryn M., Ho, Chris M. W., Dutta, Supratik, Gross, Michael L., Bowman, Gregory R.

    Published in Nature communications (06-10-2016)
    “…TEM β-lactamase confers bacteria with resistance to many antibiotics and rapidly evolves activity against new drugs. However, functional changes are not easily…”
    Get full text
    Journal Article
  14. 14

    Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin by Whitworth, Alexander J, Lee, Jeffrey R, Ho, Venus M-W, Flick, Robert, Chowdhury, Ruhena, McQuibban, G Angus

    Published in Disease models & mechanisms (01-09-2008)
    “…Parkinson's disease (PD) is a common neurodegenerative disorder caused by loss of midbrain dopaminergic neurons, the pathogenetic mechanisms of which remain…”
    Get full text
    Journal Article
  15. 15

    A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride by Antoniou, Tony, Macdonald, Erin M, Yao, Zhan, Gomes, Tara, Tadrous, Mina, Ho, Joanne M-W, Mamdani, Muhammad M, Juurlink, David N

    Published in BMC musculoskeletal disorders (22-05-2018)
    “…Dutasteride is a potent inhibitor of 5-alpha reductase enzymes that reduces concentrations of dihydrotestosterone to a greater extent than finasteride. Whether…”
    Get full text
    Journal Article
  16. 16

    Risk of serious falls associated with oxybutynin and tolterodine: a population based study by Gomes, Tara, Juurlink, David N, Ho, Joanne M-W, Schneeweiss, Sebastian, Mamdani, Muhammad M

    Published in The Journal of urology (01-10-2011)
    “…We compared the short-term risk of falls among recipients of oxybutynin or tolterodine to treat urinary incontinence. We conducted a population based,…”
    Get more information
    Journal Article
  17. 17

    Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo by Walker, Emma C, Poulton, Ingrid J, McGregor, Narelle E, Ho, Patricia WM, Allan, Elizabeth H, Quach, Julie M, Martin, T John, Sims, Natalie A

    Published in Journal of bone and mineral research (01-04-2012)
    “…Parathyroid hormone (PTH) is the only approved anabolic agent for osteoporosis treatment. It acts via osteoblasts to stimulate both osteoclast formation and…”
    Get full text
    Journal Article
  18. 18

    Liver resection for hepatocellular carcinoma in patients with cirrhosis by Wu, C.-C., Cheng, S.-B., Ho, W.-M., Chen, the late J.-T., Liu, T.-J., P'eng, F.-K.

    Published in British journal of surgery (01-03-2005)
    “…Background: Although liver resection is now a safe procedure, its role for hepatocellular carcinoma (HCC) in patients with cirrhosis remains controversial…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Total Neoadjuvant Therapy for High Risk Rectal Cancer in Western and Asian Populations – Current Evidence and Clinical Applications by Johnson, David, Li, Leung, Lee, Kin-Chung, Lam, KO, Wong, KH, Ho, WM, Ma, Brigette

    Published in Clinical colorectal cancer (01-03-2022)
    “…Recent data from several randomized controlled trials (RCTs) have shown that Total Neoadjuvant Therapy (TNT) can improve the treatment outcome of patients with…”
    Get full text
    Journal Article